| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Exelixis, Inc. (EXEL) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. EXEL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.96M | $103.88M | - | |
| Dir | 1.55M | $82.12M | - | |
| Dir | 1.19M | $62.87M | - | |
| CFO | 1.12M | $59.07M | - | |
| VP | 594.7K | $31.44M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 15, 2018 | Morrissey Michael | President And CEO | Sale+OE | 25,000 | $17.22 | $430,500.00 | -18.8% | |
| Nov 7, 2018 | Haley Patrick J.56 | Sr. Vice President, Commercial | Sell | 20,000 | $17.32 | $346,400.00 | -16.0% | |
| Nov 2, 2018 | Morrissey Michael | President And CEO | Sale+OE | 37,499 | $17.57 | $658,963.63 | -9.0% | |
| Nov 1, 2018 | Scangos George A77 | Director | Sell | 25,000 | $14.66 | $366,400.00 | -0.8% | |
| Nov 1, 2018 | Schwab Gisela67 | Pres, Prod Dev &Med Aff &CMO | Sale+OE | 12,000 | $14.16 | $169,920.00 | -3.5% | |
| Oct 1, 2018 | Morrissey Michael | President And CEO | Sale+OE | 12,501 | $17.82 | $222,767.82 | -9.1% | |
| Oct 1, 2018 | Schwab Gisela67 | Pres, Prod Dev &Med Aff &CMO | Sale+OE | 12,000 | $17.77 | $213,240.00 | -3.5% | |
| Oct 1, 2018 | Scangos George A77 | Director | Sell | 25,000 | $17.86 | $446,500.00 | -1.6% | |
| Sep 24, 2018 | Scangos George A77 | Director | Sell | 25,000 | $16.85 | $421,250.00 | -1.6% | |
| Sep 4, 2018 | Schwab Gisela67 | Pres Prod Dev &Med Aff &CMO | Sale+OE | 22,500 | $18.53 | $416,925.00 | -6.4% |